Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cancer Letters
|
September 1, 1978
The use of the D-T diaphorase for the detection of foci of early neoplastic transformation in rat liver
N A Schor
Research Communications in Chemical Pathology and Pharmacology
|
January 1, 1977
Rat liver post-microsomal D-T diaphorase: activation of the enzymes by two carcinogens
N A Schor, E Boh
Cancer Research
|
October 1, 1983
Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonic carcinomas
N A Schor, C J Cornelisse
Cancer Biochemistry Biophysics
|
January 1, 1977
The activity of the D-T diaphorase in experimental hepatomas
N A Schor, H P Morris
Enzyme
|
January 1, 1978
Carcinogens and dicumarol: opposite effects on rat liver NAD(P)H dehydrogenation
N A Schor, E Boh, V T Burke
Enzyme
|
January 1, 1983
The influence of polycyclic hydrocarbons on the activity of NAD(P)H-dehydrogenating enzymes in rat thymus. A biochemical and histochemical study
N A Schor, K Morgan, N Epstein, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|
January 1, 1982
Rat splenic D-T diaphorase and NAD(P)H-nitroblue tetrazolium reductase. Their use to assess the action of polycyclic hydrocarbons in the lymphatic system
N A Schor, R B Stedman, N Epstein, et al.
Enzyme
|
January 1, 1983
Effects of the administration of anticoagulants on the activity of the enzyme-reduced NAD(P)H dehydrogenase in rat livers, hepatomas and precarcinomatous rat liver lesions
N A Schor, R L Huddleson, G M Kane, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
February 1, 1976
Dehydrogenation of reduced pyridine nucleotides by Leydig cell tumors of the rat testis
N A Schor, B F Rice, R A Huseby, et al.
The Prostate
|
January 1, 1987
Histological findings in the rat prostate cancer model during treatment with a luteinizing hormone-releasing hormone agonist and novantrone
J I Paz-Bouza, N A Schor, E Monje, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cancer Letters
|
September 1, 1978
The use of the D-T diaphorase for the detection of foci of early neoplastic transformation in rat liver
N A Schor
Research Communications in Chemical Pathology and Pharmacology
|
January 1, 1977
Rat liver post-microsomal D-T diaphorase: activation of the enzymes by two carcinogens
N A Schor, E Boh
Cancer Research
|
October 1, 1983
Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonic carcinomas
N A Schor, C J Cornelisse
Cancer Biochemistry Biophysics
|
January 1, 1977
The activity of the D-T diaphorase in experimental hepatomas
N A Schor, H P Morris
Enzyme
|
January 1, 1978
Carcinogens and dicumarol: opposite effects on rat liver NAD(P)H dehydrogenation
N A Schor, E Boh, V T Burke
Enzyme
|
January 1, 1983
The influence of polycyclic hydrocarbons on the activity of NAD(P)H-dehydrogenating enzymes in rat thymus. A biochemical and histochemical study
N A Schor, K Morgan, N Epstein, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|
January 1, 1982
Rat splenic D-T diaphorase and NAD(P)H-nitroblue tetrazolium reductase. Their use to assess the action of polycyclic hydrocarbons in the lymphatic system
N A Schor, R B Stedman, N Epstein, et al.
Enzyme
|
January 1, 1983
Effects of the administration of anticoagulants on the activity of the enzyme-reduced NAD(P)H dehydrogenase in rat livers, hepatomas and precarcinomatous rat liver lesions
N A Schor, R L Huddleson, G M Kane, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
February 1, 1976
Dehydrogenation of reduced pyridine nucleotides by Leydig cell tumors of the rat testis
N A Schor, B F Rice, R A Huseby, et al.
The Prostate
|
January 1, 1987
Histological findings in the rat prostate cancer model during treatment with a luteinizing hormone-releasing hormone agonist and novantrone
J I Paz-Bouza, N A Schor, E Monje, et al.
Page
of 1